Stay updated on Pembrolizumab Combo in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Cervical Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the older funding/operating-status notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:15:27.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential information delays due to government funding and updated the revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:40:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a glossary toggle and the 'Revision: v3.4.0' metadata. Capitalization and wording of QC-related labels were adjusted (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').
    Difference
    0.2%
    Check dated 2026-01-28T06:35:00.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:32:33.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a Locations section including Florida. Removed the Florida Locations entry in the footer and updated the revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:35:01.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no changes to study content such as eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:38:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cervical Cancer Clinical Trial page.